Novo Nordisk A/S
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the […]
Read More
Eli Lilly’s price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk
Sopa Images | Lightrocket | Getty Images This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading day: 1. No-tech November Last week’s recovery rally allowed the Dow Jones Industrial Average and S&P 500 to both finish their seventh […]
Read More
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Drug pricing has emerged as a key topic to watch for pharmaceutical companies and investors in 2025. As President Donald Trump pushes for lower medicine prices for Americans, the sector is facing additional pricing pressure from a Biden-era law called the Inflation Reduction Act. The IRA, voted into law in 2022, allows the Centers for […]
Read More
Novo’s next-gen obesity drug shows positive results, heads to late-stage testing
The logo of Novo Nordisk is displayed at the 8th China International Import Expo. Sheldon Cooper | Lightrocket | Getty Images Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study. The drugmaker’s […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Inspire Medical, Tesla, Tegna, Oscar Health and more
Check out the companies making the biggest moves midday: Novo Nordisk — The Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Shares tumbled nearly 6%. Inspire Medical Systems — The maker of an obstructive sleep apnea treatment will benefit from Friday’s decision by the Centers […]
Read More
Holiday air travel, Novo Nordisk trial results, ‘Wicked: For Good’ debut and more in Morning Squawk
John Williams, president and chief executive officer of the Federal Reserve Bank of New York, during a farewell symposium for former De Nederlandsche Bank NV President Klaas Knot at the central bank headquarters in Amsterdam, Netherlands, on Friday, Oct. 3, 2025. Lina Selg | Bloomberg | Getty Images This is CNBC’s Morning Squawk newsletter. Subscribe here to […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more
Check out the companies making the biggest moves in premarket trading: Novo Nordisk — Shares tumbled 10% after the Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Tesla — CEO Elon Musk said on X that the company is close to finalizing its latest artificial-intelligence […]
Read More
Could markets be facing an ‘everything bubble’? Investors are divided
Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets. Some respite from a four-day sell-off followed Nvidia ‘s earnings release on Wednesday, but its own gains were quickly reversed during Thursday’s trading session as New York-listed stocks lost further ground . Friday saw U.S. stocks rebound […]
Read More
Eli Lilly hits $1 trillion market value, a first for a health-care company
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly reached a $1 trillion market capitalization on Friday, the first health-care company in the world to join the exclusive club dominated by tech firms. Eli Lilly briefly hit […]
Read More
Obesity-drugmaker Novo Nordisk helps drive Denmark’s fastest growth in years
Denmark’s economic growth accelerated in the third quarter, boosted by strong pharmaceutical exports, a key industry for the small Nordic country home to weight loss drugmaker Novo Nordisk. Denmark’s seasonally adjusted gross domestic product (GDP) grew by 2.3% in the third quarter, the largest quarter-on-quarter expansion since the fourth quarter of 2021, a preliminary reading […]
Read More